Open Label Extension Study of Romiplostim (AMG 531) in Thrombocytopenic Patients With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)

NCT00116688 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
313
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Amgen